mots-c and retatrutide RETA + Researchers are exploring how MOTS-c may interact across key metabolic pathways. 🔬 Focus areas include: ✓ Cellular energy signaling ✓ System-wide metabolic pathways ✓ Integrated research insights The Peptide That Mimics Exercise…

Meier JJ, Menge BA, Schenker N, et al

Furthermore, when the obesogenic status was reduced, the expression of amylin and GLP-1 receptors in the DVC remained stable, suggesting that even in a weight-reduced state form obesity, the DVC GLP-1R and amylin receptors theoretically remain as viable drug targets for sustaining weight loss with continued pharmacotherapy

Recommended Fiber Sources: Whole Grains: Oats, quinoa, brown rice, whole wheat bread, barley

What Clinical Trials Show After One Month of Retatrutide Phase 2 trial data (NEJM 2023) did not report week-4 weight loss as a primary endpoint

Concomitant medicines : Clinicians should review all concurrent medications, particularly insulin or sulfonylureas, given the potential for hypoglycaemia with incretin-based agents